sottoscrivi

Accedi

Frontiers Dynamic immune signatures of patients with advanced non–small-cell lung cancer for infection prediction after immunotherapy

Frontiers  Dynamic immune signatures of patients with advanced  non–small-cell lung cancer for infection prediction after immunotherapy

Frontiers Dynamic immune signatures of patients with advanced non–small-cell lung cancer for infection prediction after immunotherapy

Frontiers Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer

Frontiers Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy

Frontiers Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies

The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures

Cancers, Free Full-Text

Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma

Frontiers Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing

Cancers, Free Full-Text

Frontiers Dynamic immune signatures of patients with advanced non–small-cell lung cancer for infection prediction after immunotherapy

Cancers, Free Full-Text

Inflammatory and autoimmune predictive markers of response to anti‑PD‑1/PD‑L1 therapy in NSCLC and melanoma

The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing

Frontiers Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy

Frontiers Immunotherapy in non-small cell lung cancer: Past, present, and future directions